Dr. Mihir Wagh, MD

Claim this profile

University of Colorado - Anschutz Medical Campus

Studies Pancreatic Cyst
Studies Barrett's Esophagus
4 reported clinical trials
6 drugs studied

Affiliated Hospitals

Image of trial facility.
University Of Colorado Anschutz Medical Campus
Image of trial facility.
University Of Colorado Hospital

Clinical Trials Mihir Wagh, MD is currently running

Image of trial facility.

Endoscopic Tissue Apposition

for Gastrointestinal Endoscopy

This study is a prospective registry of patients undergoing endoscopic suturing and/or clip placement at our institution to assess the efficacy and safety of endoscopic tissue apposition. 1.1 Hypothesis: Endoscopic tissue apposition is efficacious and safe in the practice of gastrointestinal endoscopy. 1.2 Aims: To prospectively evaluate the efficacy and safety of Endoscopic Tissue Apposition in the practice of gastrointestinal endoscopy.
Recruiting1 award N/A9 criteria
Image of trial facility.

EUS-FNA With/Without MFB

for Pancreatic Cysts

Pancreatic cystic lesions (PCLs) are a common incidental finding in cross sectional imaging (up to 27% on CT scan and 41% on MRI) and pose a management challenge to physicians. According to society guidelines, PCLs with specific features should prompt additional workup with endoscopic ultrasound (EUS) for cyst characterization as well as cyst sampling. This can help determine if the cyst is mucinous or non-mucinous which has implications for its malignant potential. Cyst fluid has traditionally been sampled using EUS with fine needle aspiration (EUS-FNA) and sent for fluid analysis and cytology. More recently, the adjunctive use of the through-the-scope micro forceps (Moray micro forceps, US Endoscopy, Mentor, OH) biopsy (EUS-MFB) has shown promise for diagnosis of PCLs. This technology utilizes a micro forceps through a 19-gauge needle to biopsy the cyst wall for histology, in addition to collecting cyst fluid for CEA level and cytology. More recently, the adjunctive use of the Moray® through the needle micro forceps biopsy (EUS-MFB) has shown promise for diagnosis of PCLs. This technology utilizes a micro forceps through a 19-gauge needle to biopsy the cyst wall for histology, in addition to collecting cyst fluid for CEA level and cytology. Only a few small retrospective reports have been published regarding the use of MFB. The results of this study will hopefully help increase diagnostic yield by obtaining a histopathologic diagnosis of these PCLs, and potentially affect practice patterns of gastroenterologists and the endoscopic community, specifically those physicians who perform EUS in these patients. Furthermore, the results will help determine whether there is reason to continue this line of research to obtain a definite histologic tissue diagnosis of PCLs.
Recruiting1 award N/A2 criteria

More about Mihir Wagh, MD

Clinical Trial Related8 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Mihir Wagh, MD has experience with
  • EUS-FNA Alone
  • EUS-FNA Plus MFB
  • Seattle Protocol
  • WATS3D Brushings
  • Endoscopic Tissue Apposition
  • AGBS

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Mihir Wagh, MD specialize in?
Is Mihir Wagh, MD currently recruiting for clinical trials?
Are there any treatments that Mihir Wagh, MD has studied deeply?
What is the best way to schedule an appointment with Mihir Wagh, MD?
What is the office address of Mihir Wagh, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security